Proteinase activated receptor 2 (PAR2) modulation of airway smooth muscle function

Kimberly Black, Andrew MacKenzie, Lynette Dunning, Anne Crilly, Lorcan McGarvey, Keith Thornbury, Carl Goodyear, John Lockhart, Gary Litherland

Research output: Contribution to journalMeeting Abstractpeer-review

136 Downloads (Pure)


Chronic obstructive pulmonary disease (COPD) is a progressive lung condition characterised by airflow obstruction and irreversible lung damage. Hyperactivity and growth of airway smooth muscle (ASM) limit airflow and are key features of COPD. Proteinase activated receptor-2 (PAR2) is a key modulator of inflammatory responses in respiratory disease, such as asthma and promotes ASM relaxation. However, the precise role of the receptor in ASM in conditions such as COPD is not well understood (1). The aim of this study was to establish an ex vivo murine airway myograph assay for investigation of functional PAR2 responses to challenges relevant in COPD pathology. To achieve this, murine trachea and bronchi tissue was either mounted on a wire myograph for dynamic tension recording or processed for immunohistochemical localisation of PAR2 expression. PAR2 was present on both murine airway and lung tissue. Stimulation of PAR2 with trypsin (10 U ml-1) or activating peptide was observed to induce relaxation responses in ASM tension. Taken together this data verifies that PAR2 is present and functional in murine airways, and ex vivo modulation alters ASM tone. Ongoing experiments will investigate the effect of disease-relevant insults on this modulation in wild type and PAR2-deficient airways.
Original languageEnglish
Pages (from-to)S249-S249
Number of pages1
JournalIrish Journal of Medical Science
Issue numberSupplement 8
Publication statusPublished - 8 Oct 2018


  • PAR2
  • COPD
  • interreg va
  • airway smooth muscle


Dive into the research topics of 'Proteinase activated receptor 2 (PAR2) modulation of airway smooth muscle function'. Together they form a unique fingerprint.

Cite this